Skip to content


Emergency Products and COVID-19

BIICL is undertaking a project to assess the impact of COVID-19 on emergency products in the medical sphere.

This is a topical theme engaging important public health considerations, and involving the analysis of the law and regulation of products such as ventilators, medicines, medical devices, vaccines and related health products.

A Product Liability Forum event was organised on this theme on 4 May 2020. Speakers included Pr. Geraint Howells, Marcus Pilgerstorfer QC, Dr Peter Feldschreiber, Jeff Bucholtz of King & Spalding (Washington DC), Pr. Jean-Sebastian Borghetti, Paris II, John Wilkinson (formerly MHRA) and Pr. Eleonora Rajneri (University of Piementonti Orientale).

Various research outputs have also been generated by this project, including a blog piece by Pr. Duncan Fairgrieve, Pr. Geraint Howells and Marcus Pilgerstorfer QC.

A major paper was published by Pr. Duncan Fairgrieve, Dr Peter Feldschreiber, Pr. Geraint Howells and Marcus Pilgerstorfer QC, "Products in a Pandemic : Liability for Medical Products and the Fight against Covid-19." This paper can be downloaded here. It will be published in the European Journal of Risk Regulation.

Acceptability of a COVID-19 vaccine

Another strand of this work involves a particular focus on the COVID-19 vaccine, with an analysis of the social acceptance, legal and ethical implications of a potential COVID-19 vaccine.

This project examines the issue of the acceptability of emergency vaccines and remedies for adverse reactions by adopting an interdisciplinary methodology, examining the historical, legal, regulatory and economic, and ethical perspectives to this important issue. A number of different academics & institutions are collaborating on this project.

For further information, contact Pr. Duncan Fairgrieve  by email on

Keep In Touch